Immucell Corp ( NASDAQ: ICCC ), Biotech stock jumped more than 20 % after news from FDA



Immucell Corp ( NASDAQ: ICCC ), stock jumped after company has announced that Center for Veterinary Medicine, USFDA has accepted the data of Nisin Residue in milk. Stock jumped more than 20%. Liquidity in the stock is low and there might be a hight risk game to trade the stock.






Our Call: We think the news might not significant enough to trigger a huge upside in the stock and Traders might stay away to play the stock based on news.

Below is the news from Reuters:

ImmuCell Corporation announced that the Center for Veterinary Medicine, U.S. Food and Drug Administration (FDA) has accepted the pivotal Nisin residue data in milk and has assigned a zero milk discard time and zero meat withdrawal period. These claims are subject to obtaining the Human Food Safety (HFS) Technical Section Complete Letter and ultimately approval of the New Animal Drug Application (NADA). Zero Discard means that there would be no requirement to discard milk during treatment or for a period of time thereafter.
Tags: , , ,

About author

Make it happen !!

0 comments

Leave a Reply